Lobbying Activity Report

3291-44358

This entry has been replaced by an amended Lobbying Activity Report: 3291-44359
Organization: AbbVie Corporation
Associated registration: 10217-3291-19
Lobbying Activity date: 2025-07-14
Arranged a meeting: No
Posted date: 2025-07-21

In-house lobbyists who participated in the lobbying activity: Rami Fayed
Jennifer Humphreys
Dayna Frier
Senior Public Office Holders who were lobbied in this activity: David Eby, Premier of British Columbia
Office of the Premier
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
AbbVie Corporation engages the British Columbia Government to advocate for policies that support timely access to AbbVie’s innovative medicines for appropriate patients. More specifically, we engage with government to: Advocate of the value of innovative pharmaceuticals in improving patient outcomes and overall savings to the healthcare system, as well as advancing health security and economic growth.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
 Advanced Education, Children and Families, Colleges & Universities, Economic Development and Trade, Finances and Budgets, Health, Indigenous Relations and Reconciliation, Mental Health and Addictions, Science and Technology, Senior Citizens
 
Lobbying Activity Report replaced on: 2025-07-21 amended entry: 3291-44359
 
Senior officer who filed this Lobbying Activity Report: Rami Fayed
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.
Return to Registration for Canadian Institute for Advanced Research (CIFAR)
Date Modified: